zoledronic acid has been researched along with Polyarthritis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldring, SR; Gravallese, EM | 1 |
Bergmeister, H; Gasser, J; Görtz, B; Hayer, S; Herrak, P; Kollias, G; Redlich, K; Reiter, E; Schett, G; Smolen, JS | 1 |
Chen, NL; Diaz-Borjon, A; Lim, SS; Seyler, TM | 1 |
Bogoch, ER; Moran, EL; Pysklywec, MW | 2 |
1 review(s) available for zoledronic acid and Polyarthritis
Article | Year |
---|---|
Bisphosphonates: environmental protection for the joint?
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Bone Resorption; Collagen; Diphosphonates; Disease Progression; Imidazoles; Osteoclasts; Zoledronic Acid | 2004 |
4 other study(ies) available for zoledronic acid and Polyarthritis
Article | Year |
---|---|
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Topics: Animals; Antibodies, Monoclonal; Arthritis; Arthrography; Bone and Bones; Bone Density; Bone Resorption; Calcitonin; Cartilage, Articular; Diphosphonates; Hindlimb; Humans; Imidazoles; Infliximab; Joints; Mice; Mice, Transgenic; Osteoclasts; Osteogenesis; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Zoledronic Acid | 2004 |
Bisphosphonate-associated arthritis.
Topics: Arthritis; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Middle Aged; Pamidronate; Zoledronic Acid | 2006 |
Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis.
Topics: Animals; Arthritis; Bone Diseases, Metabolic; Carrageenan; Diphosphonates; Femur; Image Processing, Computer-Assisted; Imidazoles; Porosity; Rabbits; Stress, Mechanical; Zoledronic Acid | 1997 |
Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate).
Topics: Animals; Arthritis; Carrageenan; Diphosphonates; Disease Models, Animal; Femur; Image Processing, Computer-Assisted; Imidazoles; Injections, Subcutaneous; Knee Joint; Rabbits; Zoledronic Acid | 2000 |